|
BUYINS.NET: (RTIX) SqueezeTrigger Price is $8.005. There is
$31,091,168.00 That Short Sellers Still Need To Cover
(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:09102008
BUYINS.NET / www.squeezetrigger.com is monitoring Regeneration
Technologis (NASDAQ:RTIX) in real time and just received an alert that
is crossing above its primary SqueezeTrigger Price, the price that a
short squeeze can start in any stock. There are 3773200 shares that
have been shorted at the volume weighted average SqueezeTrigger Price
of $8.005. To access SqueezeTrigger Prices ahead of potential short
squeezes beginning, visit http://www.squeezetrigger.com .
From January 2005 to September 2008, an aggregate amount of 22827929
shares of RTIX have been shorted for a total dollar value of
$182,623,432.00. The RTIX SqueezeTrigger price of $8.005 is the volume
weighted average price that all shorts are short in shares of RTIX.
There is still approximately $31,091,168.00 of potential short covering
in shares of RTIX.
SqueezeTrigger.com has built a massive database that collects, analyzes
and publishes a proprietary SqueezeTrigger Price for each stock that
has been shorted. The data has then been integrated into an automated
trading platform which can be used to connect to a live online broker
and automate your trading of short squeeze events. It is extremely
powerful with lightening fast execution at a very low price. Both the
trading software and SqueezeTrigger data feed are available at
http://www.squeezetrigger.com .
Regeneration Technologis (NASDAQ:RTIX) Regeneration Technologies, Inc.
(RTI), incorporated in 1997, makes use of natural tissues and
technologies to produce orthopedic, cardiovascular and other surgical
implants that repair and promote the natural healing of human bone and
other human tissues and improve surgical outcomes. RTI processes human
musculoskeletal and other tissue, including bone, cartilage, tendon,
ligament, dermal and cardiovascular tissue in producing its allografts.
The Company also processes bovine tissue to produce its Sterling
xenograft line of products. Surgeons then use the Company's products to
repair and promote the healing of a range of bone and other tissue
defects, including spinal vertebrae repair, musculoskeletal
reconstruction, fracture repair, repairs to the jaw and related
tissues, and heart valve disorders, among other conditions. RTI
separates its products into four primary product lines: spinal, sports
medicine, cardiovascular and other general orthopedic. The Company's
products are distributed in all 50 states and in 10 other countries.
The Company has developed and launched, in the United States, the
BioCleanse tissue sterilization process, which is a United States Food
and Drug Administration (FDA)-reviewed, automated, pharmaceutical-grade
chemical sterilization process for musculoskeletal bone and certain
soft tissue. Bone tissue and soft tissue grafts are sterilized through
the BioCleanse process only after it has passed this screening by the
recovery agency and testing of the blood samples. The BioCleanse
process is a patented tissue sterilization process that is designed to
add a measure of safety to its bone implants by sterilizing the tissue
and providing surgeons and patient?s tissue implants that are free of
spores, fungi, bacteria and viruses. The BioCleanse process is an
automated multi-step cleansing process, which first removes blood and
fats, then chemically sterilizes the tissue, while maintaining the
structural integrity and biocompatibility of the tissue.
Spinal Products
The spinal market for allografts includes precision tooled implants and
allograft paste utilized in spinal procedures. The Company's principal
spinal allografts are the MD Series Threaded Cortical Bone Dowels, the
patent-pending CORNERSTONE Machined Allografts, TANGENT Impacted
Cortical Wedges and PRECISION GRAFT Cortical Rings. RTI also supplies
allograft paste through its Osteofil line of paste implants. During the
year ended December 31, 2005, RTI shipped over 99,000 spinal allograft
units, including bone pastes. The Company's spinal allografts are
marketed domestically through a relationship with Medtronic Sofamor
Danek.
The MD-Series Threaded Cortical Bone Dowels are used to help restore
the anatomical relationships in the lumbar area of the spine between
vertebral bodies and open spaces formed between vertebrae known as
neural foramen. The Company's dowels are threaded, providing rigid
interface with the vertebrae above and below allowing the surgeon to
provide greater stability to the surgical site. The CORNERSTONE SR
Cortical Block is used in the cervical area of the spine and is
available in both parallel and lordotic versions. The TANGENT Impacted
Cortical Wedge and PRECISON GRAFT Cortical Ring allografts are
specially designed and contoured to promote stability and restore
normal alignment in the lumbar spine.
RTI has composite allografts available for use in spinal surgery,
including a line of CORNERSTONE ASR and L-ASR cortical and cancellous
composite grafts, as well as a design for cervical spinal applications
that was completed in 2005. A new design in development for lumbar
spinal applications is due out in 2006. In addition, RTI has filed for
premarket notification, 510(k), with the FDA for a xenograft lumbar
implant, which it expects to receive approval for in 2006.
Sports Medicine Products
Many repetitive use and sports-related injuries can be addressed with
allograft implants. The most prevalent surgeries include repairs to the
anterior cruciate ligament in the knee and rotator cuff in the shoulder.
The SqueezeTrigger database of approximately 1 billion short sale
transactions goes back to January 1, 2005 and calculates the exact
price at which the Total Short Interest is short in each stock. This
data was never before available prior to January 1, 2005 because the
Self Regulatory Organizations (primary exchanges) guarded it
aggressively. After the SEC passed Regulation SHO, exchanges were
forced to allow data processors like SqueezeTrigger.com to access the
data. Total Short Interest is the number of shares shorted but not yet
covered, and is different from total short volume. To access
SqueezeTrigger Prices ahead of potential short squeezes beginning,
visit http://www.squeezetrigger.com
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide
shareholders of publicly traded US companies fight short selling.
SqueezeTrigger.com has built a proprietary database that uses Threshold
list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE
to generate detailed and useful information to combat the short selling
problem. For the first time, actual trade by trade data is available to
the public that shows the attempted size, actual size, price and
average value of short sales in stocks that have been shorted. This
information is valuable in determining the precise point at which short
sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes
and publishes a proprietary SqueezeTrigger for each stock that has been
shorted. The SqueezeTrigger database of nearly one billion short sale
transactions goes back to January 1, 2005 and calculates the exact
price at which the Total Short Interest is short in each stock. This
data was never before available prior to January 1, 2005 because the
Self Regulatory Organizations (primary exchanges) guarded it
aggressively. After the SEC passed Regulation SHO, exchanges were
forced to allow data processors like SqueezeTrigger.com to access the
data.
The SqueezeTrigger database collects individual short trade data on
over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on
nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows
by approximately 50,000,000 short sale transactions and provides
investors with the knowledge necessary to time when to buy and sell
stocks with outstanding short positions. By tracking the size and price
of each month's short transactions, SQUEEZETRIGGER.COM provides
institutions, traders, analysts, journalists and individual investors
the exact price point where short sellers start losing money and a
short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon
information believed to be reliable. The information contained herein
is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not
be considered to be all-inclusive. The companies that are discussed in
this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information
provided in reports issued by BUYINS.NET, a company affiliated with
SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This
opinion contains forward-looking statements that involve risks and
uncertainties. This material is for informational purposes only and
should not be construed as an offer or solicitation of an offer to buy
or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker
dealer, market maker, investment banker, investment advisor, analyst or
underwriter. Please consult a broker before purchasing or selling any
securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not
advise as to when it decides to sell and does not and will not offer
any opinion as to when others should sell; each investor must make that
decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock
market professionals. As a member, visitor, or user of any kind, you
accept full responsibilities for your investment and trading actions.
The contents of SQUEEZETRIGGER.COM, including but not limited to all
implied or expressed views, opinions, teachings, data, graphs,
opinions, or otherwise are not predictions, warranty, or endorsements
of any kind. Please seek stock market advice from the proper securities
professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree
to assume full responsibility for the decisions or actions that you
undertake. Global Automated Trading Systems, LLC, its owner(s),
operators, employees, partners, affiliates, advertisers, information
providers and any other associated person or entity, shall under no
circumstances be held liable to the user and/or any third party for
loss or damages of any kind, including but not limited to trading
losses, lost trading opportunity, direct, indirect, consequential,
special, incidental, or punitive damages. As a user, you agree that any
damages collected shall not exceed the amount paid to
SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that
any and all legal matters of any kind are to be reviewed and handled in
their entirety within the State of California only. By using the
services of this website, you are consenting to the terms as outlined,
and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all
examples are hypothetical and should not be considered a guarantee or
endorsement of such trading activity. SQUEEZETRIGGER.COM does not take
responsibility for problems of any kind, including but not limited to
issues with operations, data accuracy or completeness, contacting
issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places
great integrity on the data collected and distributed. This information
is deemed reliable, but not guaranteed. All information and data is
provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or
services from a securities professional. You should consider these
factors in evaluating the forward-looking statements included herein,
and not place undue reliance on such statements. The forward-looking
statements in this release are made as of the date hereof and
SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section
21E the Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may", "future", "plan" or "planned", "will" or "should", "expected,"
"anticipates", "draft", "eventually" or "projected". You are cautioned
that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results
to differ materially from those projected in the forward-looking
statements, including the risks that actual results may differ
materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a companies'
annual report on Form 10-K or 10-KSB and other filings made by such
company with the SEC.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
CONTACT: Thomas Ronk, CEO, SqueezeTrigger.com
Tel: +1 800 715 9999
e-mail: Tom@SqueezeTrigger.com
WWW: http://www.SqueezeTrigger.com
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2008 M2 Communications Ltd.
[ Back To TMCnet.com's Homepage ]
|
INDUSTRIES
INDUSTRIES
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, February 2-4, 2009. Miami, Florida.
